(1)
Mishchenko, O. Y. .; Adonkina, V. Y. .; Greshko, I. I. The Substantiation of the Cost Optimization for ER(+) HER2(−) Breast Cancer Hormone Therapy Based on the Results of the Cost Minimization Pharmacoeconomic Analysis. Soc. pharm. health care 2025, 11, 72-79.